New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Glu Mobile Inc.(NASDAQ:GLUU),Kinross Gold Corporation (USA)(NYSE:KGC), Mast Therapeutics Inc(NYSEMKT:MSTX),SUPERVALU INC.(NYSE:SVU)
Glu Mobile Inc.(NASDAQ:GLUU)’s reported the gain 6.11% to close at $4.17 with the overall traded volume of 6.12M shares. Its market capitalization on last close reached to $325.08M . Its intraday-low price was $4.00 and its hit its day's highest price at $4.24.
Glu Mobile Inc. (Glu) designs, markets and sells mobile games. The Company has developed and published a portfolio of action/adventure and casual games designed to appeal to a cross section of the users of smartphones and tablet devices who purchase its games through direct-to-consumer digital storefronts, as well as users of feature phones served by wireless carriers and other distributors.
Should GLUU a Buy or Sell Now? Find Out Here
Kinross Gold Corporation (USA)(NYSE:KGC) plunged -0.22% settle at $4.59. Its total traded volume during last trading session was 6.18M shares. The overall market worth of this company is about $5.25B. The 52 week range of the stock remained $4.23 - $9.91, while its day's lowest price was $4.50 and its hit its day's highest price at $4.59.
Kinross Gold Corporation (Kinross) is engaged in gold mining and related activities, including exploration and acquisition of gold-bearing properties, the extraction and processing of gold-containing ore, and reclamation of gold mining properties.
What KGC Charts Are Signaling for Traders? Find Out Here
Mast Therapeutics Inc(NYSEMKT:MSTX)’s reported the loss -2.52% to close at $0.560 with the overall traded volume of 6.00M shares. Its market capitalization on last close reached to $57.52 million. Its intraday-low price was $0.53 and its hit its day's highest price at $0.60.
Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates.
Should MSTX a Buy or Sell Now? Find Out Here
SUPERVALU INC.(NYSE:SVU) increase 1.59% settle at $7.04. Its total traded volume during last trading session was 5.95M shares. The overall market worth of this company is about $1.83B. The 52 week range of the stock remained $2.72 - $8.76 while its day's lowest price was $6.88 and its hit its day's highest price at $7.15.
SUPERVALU INC. (SUPERVALU) is a United States grocery channel. It operates in three segments: Retail food, Save-A-Lot and Independent business.
What SVU Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)